TRANSFUSION, Volume 56, November 2016 Ferric carboxymaltose reduces the number of red blood cell units transfused and allows transfusion independence to be obtained in patients with iron deficiency anemia secondary to gastrointestinal chronic blood loss Ugo Salvadori, 1 Marco Sandri, 2 Cristina Melli, 3 Francesca Polese, 4 Maria Simeoni, 5 Stefano Capelli, 6 and Ahmad Al-Khaffaf1 From the 1Immunohaematology and Transfusion Service, Bozen/Bolzano Hospital, and the 2Centre for Biomedicine, European ...
Read More

Aliment Pharmacol Ther 2014; 39: 176–187 Randomised clinical trial: oral vs. intravenous iron after upper gastrointestinal haemorrhage – a placebo-controlled study Bager & J. F. Dahlerup Department of Hepatology and Gastroenterology, Aarhus University Hospital, Aarhus, Denmark. Summary Background Nonvariceal acute upper gastrointestinal bleeding (AUGIB) is often accompanied by post-discharge anaemia. Aim To investigate whether iron treatment can effectively treat anaemia and to compare a 3-month regimen of oral iron treatment ...
Read More

2011;141:846–853 FERGIcor, a Randomized Controlled Trial on Ferric Carboxymaltose for Iron Deficiency Anemia in Inflammatory Bowel Disease Rayko Evstatiev,1 Phillppe Marteau,2 Tariq Iqbal,3 Igorl. Khalif,4 Jurgen Stein, 5Bernd Bokemeyer,6Ivan V. Chopey,7 Florian S. Gutzwiller,8 Lise Riopel,9 and Christoph Gasche,1 for the FERGI Study Group 1Department of Medicine 3, Division of Gastroenterology and Hepatology, Christian Doppler Laboratory for Molecular Cancer Chemoprevention, Medical University of Vienna, Vienna, Austria; 2AP-HP, Département medico-chirurgical de ...
Read More